Sign in
4

Changes in Ownership

NOVAVAX INC Filed Acc 0001209191-21-062976

President, R&D sold 8,250 shares at an average $183.82 ($1,516,552)

  • President, R&D acquired 8,250 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Glenn Gregory M · President, R&D

Table I: Non-derivative

18 lines
Date Transaction Shares Price Value Owned after D/I
2021-11-02 Exercise or conversion : show line 1 in the form +8,250 $19.08 $157,410 12,311 D
2021-11-02 Sale : show line 2 in the form −600 $177.12 $106,269 11,711 D
2021-11-02 Sale : show line 3 in the form −1,200 $178.12 $213,749 10,511 D
2021-11-02 Sale : show line 4 in the form −900 $179.09 $161,180 9,611 D
2021-11-02 Sale : show line 5 in the form −600 $180.41 $108,248 9,011 D
2021-11-02 Sale : show line 6 in the form −670 $181.55 $121,637 8,341 D
2021-11-02 Sale : show line 7 in the form −600 $182.58 $109,547 7,741 D
2021-11-02 Sale : show line 8 in the form −800 $183.58 $146,860 6,941 D
Open-market sales · 8,250 sh · avg $183.82 · $1,516,552

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-11-02 Exercise or conversion : show line 19 in the form Stock Option (Right to Buy) −8,250 $19.08 2030-04-17 8,250 123,750 D
Loading xslF345X03/doc4.xml…